These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
452 related articles for article (PubMed ID: 17891441)
21. Value of sentinel lymph node biopsy in breast ductal carcinoma in situ upstaged to invasive carcinoma. Sakr R; Antoine M; Barranger E; Dubernard G; Salem C; Daraï E; Uzan S Breast J; 2008; 14(1):55-60. PubMed ID: 18186866 [TBL] [Abstract][Full Text] [Related]
22. Tumor size as predictor of microinvasion, invasion, and axillary metastasis in ductal carcinoma in situ. Maffuz A; Barroso-Bravo S; Nájera I; Zarco G; Alvarado-Cabrero I; Rodríguez-Cuevas SA J Exp Clin Cancer Res; 2006 Jun; 25(2):223-7. PubMed ID: 16918134 [TBL] [Abstract][Full Text] [Related]
23. Role of sentinel lymph node biopsy in high-risk ductal carcinoma in situ patients. Moran CJ; Kell MR; Flanagan FL; Kennedy M; Gorey TF; Kerin MJ Am J Surg; 2007 Aug; 194(2):172-5. PubMed ID: 17618799 [TBL] [Abstract][Full Text] [Related]
24. Is it possible to refine the indication for sentinel node biopsy in high-risk ductal carcinoma in situ? Fraile M; Gubern JM; Rull M; Julián FJ; Serra C; Llatjós M; Culell P; Puig P; Solà M; Vallejos V; Mariscal A; Janer J; Deulofeu P; Fusté F Nucl Med Commun; 2006 Oct; 27(10):785-9. PubMed ID: 16969260 [TBL] [Abstract][Full Text] [Related]
25. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS? Cox CE; Nguyen K; Gray RJ; Salud C; Ku NN; Dupont E; Hutson L; Peltz E; Whitehead G; Reintgen D; Cantor A Am Surg; 2001 Jun; 67(6):513-9; discussion 519-21. PubMed ID: 11409797 [TBL] [Abstract][Full Text] [Related]
26. Symmetrization reduction mammaplasty combined with sentinel node biopsy in patients operated for contralateral breast cancer. Schrenk P; Wölfl S; Bogner S; Huemer GM; Wayand W J Surg Oncol; 2006 Jul; 94(1):9-15. PubMed ID: 16788937 [TBL] [Abstract][Full Text] [Related]
27. Can magnetic resonance imaging be used to select patients for sentinel lymph node biopsy in prophylactic mastectomy? McLaughlin SA; Stempel M; Morris EA; Liberman L; King TA Cancer; 2008 Mar; 112(6):1214-21. PubMed ID: 18257089 [TBL] [Abstract][Full Text] [Related]
28. Is there an indication for sentinel node biopsy in patients with ductal carcinoma in situ of the breast? A review. van Deurzen CH; Hobbelink MG; van Hillegersberg R; van Diest PJ Eur J Cancer; 2007 Apr; 43(6):993-1001. PubMed ID: 17300928 [TBL] [Abstract][Full Text] [Related]
29. The use of sentinel lymph node biopsy in ductal carcinoma in situ. Schneider C; Trocha S; McKinley B; Shaw J; Bielby S; Blackhurst D; Jones Y; Cornett W Am Surg; 2010 Sep; 76(9):943-6. PubMed ID: 20836339 [TBL] [Abstract][Full Text] [Related]
30. [Prognostic and curative value of sentinel node in breast cancer. A 377 patients experience]. Iannace C; Di Libero L; Lepore M; De Stefano N; Buono M; Sciascia V; Manetta F; Giordano M; Scetta G; Varriale R; Esposito D; Tartaglia E; Ferbo U; Miletto P; Caracciolo F Ann Ital Chir; 2010; 81(2):103-11; discussion 112-3. PubMed ID: 20726388 [TBL] [Abstract][Full Text] [Related]
31. Multicentric breast cancer: a new indication for sentinel node biopsy--a multi-institutional validation study. Knauer M; Konstantiniuk P; Haid A; Wenzl E; Riegler-Keil M; Pöstlberger S; Reitsamer R; Schrenk P J Clin Oncol; 2006 Jul; 24(21):3374-80. PubMed ID: 16849751 [TBL] [Abstract][Full Text] [Related]
32. Implementation of sentinel node biopsy in breast cancer patients in the Netherlands. Ho VK; van der Heiden-van der Loo M; Rutgers EJ; van Diest PJ; Hobbelink MG; Tjan-Heijnen VC; Dirx MJ; Reedijk AM; van Dijck JA; van de Poll-Franse LV; Schaapveld M; Peeters PH Eur J Cancer; 2008 Mar; 44(5):683-91. PubMed ID: 18314328 [TBL] [Abstract][Full Text] [Related]
33. Factors associated with lymph node assessment in ductal carcinoma in situ: analysis of 1988-2002 seer data. Porembka MR; Abraham RL; Sefko JA; Deshpande AD; Jeffe DB; Margenthaler JA Ann Surg Oncol; 2008 Oct; 15(10):2709-19. PubMed ID: 18483831 [TBL] [Abstract][Full Text] [Related]
34. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up. Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650 [TBL] [Abstract][Full Text] [Related]
35. Sentinel node biopsy in larger or multifocal breast cancers: to do or not to do. Behm EC; Buckingham JM ANZ J Surg; 2008 Mar; 78(3):151-7. PubMed ID: 18269478 [TBL] [Abstract][Full Text] [Related]
36. An argument against routine sentinel node mapping for DCIS. Farkas EA; Stolier AJ; Teng SC; Bolton JS; Fuhrman GM Am Surg; 2004 Jan; 70(1):13-7; discussion 17-8. PubMed ID: 14964539 [TBL] [Abstract][Full Text] [Related]
37. Utility of intraoperative frozen section examination of sentinel lymph nodes in ductal carcinoma in situ of the breast. Ballehaninna UK; Chamberlain RS Clin Breast Cancer; 2013 Oct; 13(5):350-8. PubMed ID: 23791128 [TBL] [Abstract][Full Text] [Related]
38. Sentinel lymph node biopsy in contralateral prophylactic mastectomy: are we overtreating? Experience at a tertiary care hospital. Kuwajerwala NK; Dekhne NS; Pentiak PA; Fend D; Callahan RE; Amine M; Lucia V; Swartz J Clin Breast Cancer; 2013 Aug; 13(4):287-91. PubMed ID: 23706482 [TBL] [Abstract][Full Text] [Related]
39. Microinvasive breast cancer and the role of sentinel node biopsy: an institutional experience and review of the literature. Guth AA; Mercado C; Roses DF; Darvishian F; Singh B; Cangiarella JF Breast J; 2008; 14(4):335-9. PubMed ID: 18537917 [TBL] [Abstract][Full Text] [Related]
40. Predictors of invasion and axillary lymph node metastasis in patients with a core biopsy diagnosis of ductal carcinoma in situ: an analysis of 255 cases. Han JS; Molberg KH; Sarode V Breast J; 2011; 17(3):223-9. PubMed ID: 21545433 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]